AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer

Publication | Closed Access

DOI

Citations

References

2018

Year

George Pentheroudakis, Vassiliki Kotoula, Georgia-Angeliki Koliou, Vasilios Karavasilis, Epaminontas Samantas, Gerasimos Aravantinos, Lydia Kalogeropoulou, Ioannis Souglakos, Nikolaos Kentepozidis, G. Koumakis,

Clinical Colorectal Cancer

Single-arm StudyAflibercept MaintenanceGastrointestinal OncologyMedicineCancer ManagementPharmacologyPathologyColorectal CancerMetastatic Colorectal CancerPharmacotherapyMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer Research